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Heart Transplant Program Offers a New Lease on Life
Russell Cerminara is not someone you would readily identify as a patient in a hospital, let alone someone
on the heart donor list. Casually dressed and exceedingly well groomed, he lounges comfortably in the
waiting area outside his room on the 5th floor of the Gibbon Building – the Cardiac Unit – at Jefferson
University Hospital. If it weren’t for the IV stand, and the small black Jansport backpack that holds a
device pumping his heart, you’d never know he’d spent the last decade battling a life-threatening heart
condition and been in the hospital since April.

Every bit the image of a successful television producer, Mr. Cerminara takes calls on his blackberry when
not doing physical therapy or interacting with other patients and family members. He’s working to gain
enough strength to go home while he waits for a heart, which could be a while given his O blood type.

Medicare Certified...the highest quality indicator for a transplant program, based on the
number of transplants and clinical outcomes.
On May 24, 2007, he received a Jarvik 2000® Heart Assist System. This is the smallest and simplest of
the axial flow pumps in existence right now – the latest technology in LVADs (Left Ventricle Assist
Devices), invented by Dr. Robert Jarvik. Rather than taking over for the heart, the Jarvik assists the
patient’s weakened left ventricle to pump blood throughout the body. Jefferson was the first hospital in
Philadelphia to offer the groundbreaking device, which has not yet been approved by the FDA as standard
treatment.
Mr. Cerminara is but one success story in a young but impressive and growing Heart Transplant Program
at Jefferson – which was Medicare Certified after only a very short time. This is the highest quality
indicator for a transplant program, based on the number of transplants and clinical outcomes as well as
skill and professionalism of the medical and surgical teams. For patients with serious cardiac failure, this
makes Jefferson a financially viable option for treatment.
The surgical team benefits from a new surgical suite that contains miniature equipment as well as stateof-the-art video monitoring devices. James Diehl, MD, Director of the Division of Cardiothoracic Surgery,

says that this makes more seamless procedures possible that integrate endoscopy as well as minimally
invasive cardiac surgery techniques. "What is more," he says, "everyone in the operating room can see the
procedures with exceptional clarity."
The quality of care speaks for itself. "I’m going to make a television show about this disease, treatment
process, and this device," says Mr. Cerminara. "Because the public in general is very unaware of it, like I
was." His continued recovery is sure to make this possible, and will make for another of the compelling
and positive stories to which he continues to be so devoted to telling.

The Surgeon Speaks
"There are several surgical advantages to the Jarvik Heart for a patient like Russ Cerminara. Like all
LVADs, it is implanted with the use of a heart and lung machine, but it is less invasive and more gentle on
the heart itself. Patients rarely need blood transfusions. And it can be implanted through the left chest,
which is less risky for the patient because it avoids creating dangerous scar tissue in the middle chest."
"While Russ had battled heart failure for many years, he had been successful with various other
treatments. It was only when we saw that he was no longer responsive to these therapies that it became
clear how limited his options really were."
"He agreed it was time to begin the evaluation process for a heart transplant, and just a week before he
was to come in to start the tests, he was rushed to the hospital and we decided the LVAD was necessary.
At that point it was lifesaving. And now, as Russ gains strength, we’re even more optimistic about the
potential outcomes when a heart does become available."
Scott C. Silvestry, MD
Director, Heart Transplantation and Cardiac Mechanical Assist Program
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Heart Transplant Program Offers a New Lease on Life
The Surgeon Speaks
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ussell Cerminara is not someone you
would readily identify as a patient in
a hospital, let alone someone on the
heart donor list. Casually dressed and
exceedingly well groomed, he lounges
comfortably in the waiting area outside
his room on the 5th floor of the Gibbon
Building – the Cardiac Unit – at Jefferson
University Hospital. If it weren’t for the IV
stand, and the small black Jansport
backpack that holds a device pumping
his heart, you’d never know he’d spent the
last decade battling a life-threatening
heart condition and been in the hospital
since April.
Every bit the image of a successful
television producer, Mr. Cerminara takes
calls on his blackberry when not doing
physical therapy or interacting with other
patients and family members. He’s
working to gain enough strength to go
home while he waits for a heart, which
could be a while given his O blood type.

Medicare Certified...the
highest quality indicator for a
transplant program, based on
the number of transplants
and clinical outcomes
On May 24, 2007, he received a Jarvik
2000® Heart Assist System. This is the
smallest and simplest of the axial flow
pumps in existence right now – the latest
technology in LVADs (Left Ventricle Assist
Devices), invented by Dr. Robert Jarvik.
Rather than taking over for the heart, the
Jarvik assists the patient’s weakened left
ventricle to pump blood throughout the
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“There are
several surgical
advantages to
the Jarvik Heart
for a patient like Russ Cerminara.
Like all LVADs, it is implanted with the
use of a heart and lung machine, but
it is less invasive and more gentle on
the heart itself. Patients rarely need
blood transfusions. And it can be
implanted through the left chest, which
is less risky for the patient because it
avoids creating dangerous scar tissue
in the middle chest.
Thanks to Jefferson surgeons, television producer Russ Cerminara now benefits from a
portable Jarvik 2000® Heart Assist System while he waits for a donor heart.

body. Jefferson was the first hospital in
Philadelphia to offer the groundbreaking
device, which has not yet been approved
by the FDA as standard treatment.
Mr. Cerminara is but one success story in
a young but impressive and growing
Heart Transplant Program at Jefferson –
which was Medicare Certified after only
a very short time. This is the highest
quality indicator for a transplant
program, based on the number of
transplants and clinical outcomes as
well as skill and professionalism of the
medical and surgical teams. For patients
with serious cardiac failure, this makes
Jefferson a financially viable option
for treatment.
The surgical team benefits from a
new surgical suite that contains
miniature equipment as well as
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state-of-the-art video monitoring devices.
James Diehl, MD, Director of the Division
of Cardiothoracic Surgery, says that this
makes more seamless procedures possible
that integrate endoscopy as well as
minimally invasive cardiac surgery
techniques. “What is more, he says,
“everyone in the operating room can see
the procedures with exceptional clarity.”
The quality of care speaks for itself.
“I’m going to make a television show
about this disease, treatment process, and
this device,” says Mr. Cerminara.
“Because the public in general is very
unaware of it, like I was.” His continued
recovery is sure to make this possible, and
will make for another of the compelling
and positive stories to which he continues
to be so devoted to telling.
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“While Russ had battled heart failure
for many years, he had been successful
with various other treatments. It was
only when we saw that he was no
longer responsive to these therapies
that it became clear how limited his
options really were.
“He agreed it was time to begin
the evaluation process for a heart
transplant, and just a week before
he was to come in to start the tests,
he was rushed to the hospital and we
decided the LVAD was necessary. At
that point it was lifesaving. And now, as
Russ gains strength, we’re even more
optimistic about the potential outcomes
when a heart does become available.”
Scott C. Silvestry, MD
Director, Heart Transplantation and
Cardiac Mechanical Assist Program
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